Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In 2002, we reported the initial results of a trial comparing radical prostatectomy with watchful waiting in the management of early prostate cancer. After three more years of follow-up, we report estimated 10-year results. METHODS: From October 1989 through February 1999, 695 men with early prostate cancer (mean age, 64.7 years) were randomly assigned to radical prostatectomy (347 men) or watchful waiting (348 men). The follow-up was complete through 2003, with blinded evaluation of the causes of death. The primary end point was death due to prostate cancer; the secondary end points were death from any cause, metastasis, and local progression. RESULTS: During a median of 8.2 years of follow-up, 83 men in the surgery group and 106 men in the watchful-waiting group died (P=0.04). In 30 of the 347 men assigned to surgery (8.6 percent) and 50 of the 348 men assigned to watchful waiting (14.4 percent), death was due to prostate cancer. The difference in the cumulative incidence of death due to prostate cancer increased from 2.0 percentage points after 5 years to 5.3 percentage points after 10 years, for a relative risk of 0.56 (95 percent confidence interval, 0.36 to 0.88; P=0.01 by Gray's test). For distant metastasis, the corresponding increase was from 1.7 to 10.2 percentage points, for a relative risk in the surgery group of 0.60 (95 percent confidence interval, 0.42 to 0.86; P=0.004 by Gray's test), and for local progression, the increase was from 19.1 to 25.1 percentage points, for a relative risk of 0.33 (95 percent confidence interval, 0.25 to 0.44; P<0.001 by Gray's test). CONCLUSIONS: Radical prostatectomy reduces disease-specific mortality, overall mortality, and the risks of metastasis and local progression. The absolute reduction in the risk of death after 10 years is small, but the reductions in the risks of metastasis and local tumor progression are substantial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the “gold standard” treatments for early stage prostate cancer is radical prostatectomy (RP), which has established long-term benefit (2-5).”
From Men's experience with penile rehabilitation following radical prostatectomy: a qualitative study with the goal of informing a therapeutic intervention. (2015) · cites this paper as [2]
Citations
Cites
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
Self-citationA Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Häggman, M., Andersson, S.-O., Spångberg, A., Busch, C., Nordling, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012794 · Cited by 817
Self-citationQuality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Self-citationNatural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
Self-citationPotosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
The role of radical prostatectomy in the management of prostatic cancer
Walsh, P. C., & Lepor, H. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<526::aid-cncr2820601515>3.0.co;2-9 · Cited by 131
Carcinoma of the prostate. Hormonal therapy
Grayhack, J. T., Keeler, T. C., & Kozlowski, J. M. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<589::aid-cncr2820601526>3.0.co;2-r · Cited by 111
Staging Pelvic Lymphadenectomy for Carcinoma of the Prostate: Risk Versus Benefit
Brendler, C. B., Cleeve, L. K., Anderson, E. E., & Paulson, D. F. (1980) · The Journal of Urology · doi:10.1016/s0022-5347(17)55696-7 · Cited by 106
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden
Johansson, J.-E. (1997) · JAMA · doi:10.1001/jama.277.6.467 · Cited by 102
Self-citation
Research works printed but not linked: 1
- 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T · doi:10.1002/1097-0142(19930715)72:2<310::aid-cncr2820720203>3.0.co;2-t
Cited by
Items 701–800 of 999
von Below, C., Wassberg, C., Norberg, M., Tolf, A., Kullberg, J., Ladjevardi, S., Häggman, M., Axelson, A. B., & Ahlström, H. K. (2017) · Scandinavian Journal of Urology · doi:10.1080/21681805.2017.1281346 · Cited by 6
Self-citationEvaluation of an Internet-Based Disease Trajectory Decision Tool for Prostate Cancer Screening
Bhatnagar, V., Frosch, D. L., Tally, S. R., Hamori, C. J., Lenert, L. A., & Kaplan, R. M. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00407.x · Cited by 6
Avoiding surgery in prostate cancer patients with low-risk disease
MOURAVIEV, V. B., & Polascik, T. J. (2008) · Therapy · doi:10.2217/14750708.5.1.25 · Cited by 6
Nakano, M., Takahashi, H., Shiraishi, T., Lu, T., Furusato, M., Wakui, S., & Hano, H. (2008) · Pathology International · doi:10.1111/j.1440-1827.2008.02246.x · Cited by 6
Prostate Cancer: An Evolving Paradigm
Caso, J., MOURAVIEV, V. B., Tsivian, M., Polascik, T. J., & Moul, J. W. (2010) · Journal of Endourology · doi:10.1089/end.2009.0539 · Cited by 6
Cryotherapy for Prostate Cancer
Miller, D. C., Pisters, L. L., & Belldegrun, A. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00105-5 · Cited by 6
Poissonnier, L., Murat, F. J., Chapelon, J., & Gelet, A. (2007) · Annales d Urologie · doi:10.1016/j.anuro.2007.08.004 · Cited by 6
Expectant management: an option for localized prostate cancer
Khan, M. A., & Partin, A. W. (2005) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500824 · Cited by 6
Technology Assessment: Vigilance Required
Lee, W. R. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.09.030 · Cited by 6
Schulz, R. J., & Kagan, A. R. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn443 · Cited by 6
Decision-Making in Clinically Localized Prostate Cancer: Evaluating and Communicating Risks
Sartor, O. A. (2008) · Clinical Genitourinary Cancer · doi:10.3816/cgc.2008.n.010 · Cited by 6
Second Acta Oncologia Symposium on Prostate Cancer Controversies
Levitt, S. H. (2005) · Acta Oncologica · doi:10.1080/02841860500251919 · Cited by 6
DOES ROBOTICALLY ASSISTED RADICAL PROSTATECTOMY RESULT IN BETTER PRESERVATION OF ERECTILE FUNCTION?
Goldstraw, M. A., DASGUPTA, P., Anderson, C. J., Patil, K., & Kirby, R. S. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06319.x · Cited by 6
EXTRAPERITONEOSCOPIC RADICAL PROSTATECTOMY AFTER PELVIC SUGERY PROCEDURES
Serniak, Y. P., Sagalevych, A. I., Frolov, O. S., Sernyak, P. Y., & Кривопустов, М. С. (2020) · Wiadomości Lekarskie · doi:10.36740/wlek202006102 · Cited by 5
Wagner, H. E., Kenk, M., Fraser, M. E., Berlín, A., & Fleshner, N. E. (2021) · European Urology Focus · doi:10.1016/j.euf.2021.06.002 · Cited by 5
SUPPORTING THE SUPPORTER: HELPING THE PARTNER OF PATIENTS NEWLY DIAGNOSED WITH PROSTATE CANCER
Kirby, R. S., Holmes, K., & Amoroso, P. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09403.x · Cited by 5
Erectile function after robotic nerve sparing and semi-sparing of the neurovascular bundles
Nilsson, A. E., Carlsson, S., Jonsson, N. M., Onelöv, E., Steineck, G., & Wiklund, P. N. (2007) · Journal of Robotic Surgery · doi:10.1007/s11701-007-0034-x · Cited by 5
Rubio‐Briones, J., Iborra, I., Trassierra, M., Collado, A., Casanova, J., Gomez-Ferrer, A., Ricós, J. V., Monrós, J. L., Dumont, R., & Solsona, E. (2010) · Actas Urológicas Españolas (English Edition) · doi:10.1016/s2173-5786(10)70149-9 · Cited by 5
Actualización en cáncer de próstata
Martínez, B. M.-A., Durán, M., Encinas, M. S., & Villaverde, R. M. (2013) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(13)70509-2 · Cited by 6
Love, faith and hope – a secondary analysis of prostate cancer survivors and their partners
O'Shaughnessy, P. ‘., Laws, T. A., & Esterman, A. (2015) · Contemporary Nurse · doi:10.1080/10376178.2015.1101352 · Cited by 9
PSA 2010 – Aufbruch in eine neue Ära der Früherkennung des Prostatakarzinom
Börgermann, C., Sieverding, M., Fornara, P., Graefen, M., Hammerer, P., Semjonow, A., Schröder, F. H., & Rubben, H. (2006) · Der Urologe · doi:10.1007/s00120-006-1173-9 · Cited by 5
Lyth, J., Andersson, S., Andrén, O., Johansson, J., Carlsson, P., & Shahsavar, N. (2011) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365599.2011.615759 · Cited by 5
Self-citation„Active surveillance“ des lokalisierten Prostatakarzinoms
Czeloth, K., & Albers, P. (2007) · Der Onkologe · doi:10.1007/s00761-007-1229-5 · Cited by 5
Optimal cost-effective staging evaluations in prostate cancer
Lacy, G. L., Soderdahl, D. W., & Hernández, J. (2007) · Current Urology Reports · doi:10.1007/s11934-007-0005-9 · Cited by 5
YOUNG MEN WITH PROSTATE CANCER: ARE THEY DIFFERENT AND HOW SHOULD THEY BE MANAGED?
Hotston, M. R., Burden, H. P., Thurairaja, R., McFarlane, J., & Persad, R. A. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.06534.x · Cited by 5
Active surveillance for favorable-risk prostate cancer: What are the results and how safe is it?
Klotz, L. H. (2007) · Current Urology Reports · doi:10.1007/s11934-007-0027-3 · Cited by 5
ACTIVE SURVEILLANCE: A SAFE, LOW‐COST PROGNOSTIC TEST FOR PROSTATE CANCER
Zietman, A. L. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07553.x · Cited by 5
Tadayyon, F., Mellat, M., Alizadeh, F., Hadi, M., Khorrami, M. H., Yazdani, M., & Joozdani, R. (2013) · Advanced Biomedical Research · doi:10.4103/2277-9175.107963 · Cited by 5
Crioterapia prostática como tratamiento primario en pacientes con cáncer de próstata
Johansen, T. E. B. (2007) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(07)73702-6 · Cited by 5
LAPAROSCOPY OR ROBOTICS: WHERE DOES THE FUTURE LIE?
Patil, K., Kirby, R. S., Hicks, J. A., & Stolzenburg, J. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08782.x · Cited by 5
Adult Genitourinary Cancer—Prostate and Bladder
Malkowicz, S. B., Vaughn, D. J., & Wein, A. J. (2007) · Elsevier eBooks · doi:10.1016/b978-141603848-1.10015-4 · Cited by 5
The Scandinavian prostate cancer group study: the case for conservative management
Parker, C. C. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05794.x · Cited by 5
Prostate Cancer Prevention Trial
Weizer, A. Z., & Hussain, M. (2008) · Wiley Encyclopedia of Clinical Trials · doi:10.1002/9780471462422.eoct629 · Cited by 5
Management of prostate cancer. Part 2: localized and locally advanced disease
Sooriakumaran, P., Khaksar, S., & Shah, J. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.4.595 · Cited by 5
Saito, R., Tanaka, N., Aizawa, T., Imoto, H., Yamamura, A., Aoki, T., Kawamorita, N., Musha, H., Ohnuma, S., Motoi, F., et al. (2020) · Journal of Surgical Case Reports · doi:10.1093/jscr/rjaa150 · Cited by 4
Perspective on prostate cancer screening
Rogers, C. S. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02456.x · Cited by 4
Non-surgical treatment of localised prostate cancer
Moule, R. N., & Hoskin, P. (2009) · Surgical Oncology · doi:10.1016/j.suronc.2009.03.006 · Cited by 4
Brown, M. A., Cato, L., & Jeselsohn, R. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00029-9 · Cited by 8
Escarela, G., Ruiz-de-Chavez, J., & Castillo‐Morales, A. (2013) · Statistical Methods in Medical Research · doi:10.1177/0962280213492406 · Cited by 4
Expectant Management of Prostate Cancer
Eastham, J. A., & Scardino, P. T. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00101-8 · Cited by 4
Should patients consider active surveillance?
Albertsen, P. C. (2008) · Cancer · doi:10.1002/cncr.23500 · Cited by 4
Klotz, L. H. (2008) · Nature Clinical Practice Urology · doi:10.1038/ncpuro1131 · Cited by 4
Borden, L. S., & Kozlowski, P. M. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.400 · Cited by 4
Should men over the age of 65 years receive PSA screening? Argument against
Albertsen, P. C. (2008) · Nature Clinical Practice Urology · doi:10.1038/ncpuro1079 · Cited by 4
Dépistage du cancer de la prostate : synthèse
Mongiat-Artus, P., & Teillac, P. (2006) · Annales d Urologie · doi:10.1016/j.anuro.2006.01.009 · Cited by 4
Trends in Prostate Cancer Screening: Overview of the UK
Bryant, R. J., & Hamdy, F. C. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-281-0_2 · Cited by 5
Radical prostatectomy for early prostate cancer improves long term survival
Alibhai, S. M. H., & Gogov, S. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2005.09.008 · Cited by 4
Prostate Cancer Care Before and After Medicare Eligibility
Huesch, M. D., & Ong, M. K. (2016) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/0046958016647298 · Cited by 4
Should Canadians be offered systematic prostate cancer screening? No.
Labrecque, M., Légaré, F., & Cauchon, M. (2007) · PubMed Central · Cited by 4
Montorsi, F. (2013) · European Urology · doi:10.1016/j.eururo.2013.05.056 · Cited by 4
Evidence-based medicine in prostate cancer: where do we stand in 2006?
Dahm, P. (2006) · Current Opinion in Urology · doi:10.1097/01.mou.0000193395.00340.3e · Cited by 7
Revisiting my personal decision about prostate‐specific antigen testing in 2005
Barry, M. J. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05796.x · Cited by 4
Intoxicated by technology: are we keeping our eyes on the prize?
Scardino, P. T. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0803 · Cited by 4
Penson, D. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0353 · Cited by 4
Radical Surgery or Watchful Waiting in Prostate Cancer
Yang, Z., McCaw, Z. R., & Yin, G. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1900410 · Cited by 4
1010 Under-treatment of men in their seventies with high risk, non-metastatic prostate cancer
Stattin, P., Folkvaljon, Y., Eriksson, M. H., Akre, O., Carlsson, S., Drevin, L., Lissbrant, I. F., Makarov, D., Loeb, S., & Bratt, O. (2015) · European Urology Supplements · doi:10.1016/s1569-9056(15)60998-8 · Cited by 4
Gene Expression Profile, Androgen Independence and Prostate Cancer
Omabe, M., Onyeanusi, J. C., Amos, N., Ezeani, M., & Okekpa, S. I. (2012) · Journal of Cancer Therapy · doi:10.4236/jct.2012.35082 · Cited by 3
Shafiee, M., Fard, E. S., Taghvimi, S., Movahedpour, A., Mousavi, P., Rezaeijo, S. M., Khatami, S. H., & Azadbakht, O. (2025) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2025.111671 · Cited by 4
Stand der Prostatakarzinomvorsorge im Jahr 2008
Arndt, B., KWIATKOWSKI, M. K., & Recker, F. (2008) · Der Urologe · doi:10.1007/s00120-008-1777-3 · Cited by 3
Advanced topics in evidence-based urological oncology: Using results of a subgroup analysis
Scales, C. D., & Canfield, S. E. (2011) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.01.007 · Cited by 4
Albertsen, P. C. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0679 · Cited by 3
Actitud expectante en el adenocarcinoma incidental de próstata
Pascual, E. J. M., Sacoto, C. D. C., Villa, M. T., Moreno, J. L. P., Cerdá, J. L. R., & Cruz, J. F. J. (2010) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2010.06.006 · Cited by 3
How to preserve potency and continence in localized prostate cancer
BREDA, G., & Celia, A. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.06950.x · Cited by 3
Place de la prostatectomie radicale dans le traitement du cancer de prostate
Long, J., Thuillier, C., Terrier, N., Descotes, J., & Rambeaud, J. (2011) · Médecine Nucléaire · doi:10.1016/j.mednuc.2011.04.005 · Cited by 3
The natural and treated history of prostate cancer
Garzotto, M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511551994.004 · Cited by 3
Aktuelle Therapie des fortgeschrittenen Prostatakarzinoms
Ponholzer, A., Steinbacher, F., Stephan Madersbacher, A., & Schramek, P. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-011-0014-7 · Cited by 3
Moran, B. J., DeRose, P. M., Hsu, I.-C. J., Abdel–Wahab, M., Arterbery, V. E., Ciezki, J. P., Frank, S. J., Mohler, J. L., Rosenthal, S. A., Rossi, C. J., et al. (2011) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3182354a65 · Cited by 4
Rabah, D. M., Alkhateeb, S., Abusamra, A. J., Alotaibi, M., Mahmood, R. I., Al-Mansour, M. M., Murshid, E., Alsharm, A. A., Alolayan, A. A. M., Ahmad, I., et al. (2014) · Urology Annals · doi:10.4103/0974-7796.140959 · Cited by 3
Chew, L., Chang, C., & Simhan, J. (2023) · International Journal of Impotence Research · doi:10.1038/s41443-023-00714-4 · Cited by 3
Sælen, M. G., Hjelle, L. V., Aarsæther, E., Knutsen, T., Andersen, S., Bentzen, A. G., Richardsen, E. H., Fosså, S. D., & Haugnes, H. S. (2023) · Acta Oncologica · doi:10.1080/0284186x.2023.2224051 · Cited by 3
The Role of Nutrition and Diet in Prostate Cancer
Mucci, L. A., & Giovannucci, E. L. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-542-2_8 · Cited by 3
Oliver, R. T. D., Lörincz, A. T., & Cuzick, J. M. (2008) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-69297-3_18 · Cited by 3
Huang, R. C. ‐., Auvinen, A. P., Hakama, M., Tammela, T. L. J., Ala‐Opas, M., Leppilahti, M., Vornanen, T., & Chen, H. (2012) · Health Expectations · doi:10.1111/j.1369-7625.2012.00802.x · Cited by 3
Han, L. C., Delpe, S. D., Shah, N. D., Ziegenfuss, J. Y., Tilburt, J. C., Karnes, R. J., Nguyen, P. L., Gross, C. P., Yu, J. B., Trinh, Q., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.02.001 · Cited by 3
Kirby, R. S. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0210 · Cited by 3
Dariane, C., Cossec, C. L., Drouin, S., Wolff, B., Granger, B., Mozer, P., Bitker, M., Shariat, S. F., Cussenot, O., & Morgan Rouprêt, A. (2013) · World Journal of Urology · doi:10.1007/s00345-013-1089-0 · Cited by 3
Health-related quality-of-life effects of watchful waiting re-evaluated in SPCG-4
McDermott, D. W., & Sanda, M. G. (2009) · Nature Reviews Urology · doi:10.1038/ncpuro1314 · Cited by 3
Survival from prostate cancer in England and Wales up to 2001
Clarke, N. W. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604596 · Cited by 3
Konstantinos Hatzimouratidis, A., Moysidis, K., Bekos, A., Giakoumelos, A., & Hatzichristou, D. G. (2008) · Journal of Endourology · doi:10.1089/end.2008.9751 · Cited by 3
Active surveillance vs radical prostatectomy
Abrahamsson, P. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.06949.x · Cited by 3
Carter, C., Stallworth, J., & Holleman, R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1160-8.10040-5 · Cited by 3
Supporting the supporter: helping the partner of patients newly diagnosed with prostate cancer
Kirby, R. S., Holmes, K., & Amoroso, P. (2012) · Trends in Urology & Men s Health · doi:10.1002/tre.246 · Cited by 3
Nouhi, M., Mousavi, S. M., Olyaeemanesh, A., Shaksisalim, N., & Sari, A. A. (2019) · Iranian Journal of Public Health · doi:10.18502/ijph.v48i4.978 · Cited by 3
Le cancer de la prostate, le point sur le dépistage
Grosclaude, P. (2008) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32741-4 · Cited by 3
Michalski, J. M., Pisansky, T. M., Lawton, C. A., & Potters, L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24098-7.00053-8 · Cited by 5
Yang, C., Lin, Y., Ou, Y., Weng, W., Huang, L., Lu, C.-H., Hsu, C. Y., & Tung, M. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i5.1026 · Cited by 3
Let sleeping dogs lie? What men should know before getting tested for prostate cancer
Chapman, S. F., Barrett, A., & Stockler, M. R. (2010) · Sydney University Press eBooks · doi:10.30722/sup.9781920899684 · Cited by 3
Treatment of early prostate cancer: radical prostatectomy
Coull, N., & Thompson, A. C. (2009) · Trends in Urology Gynaecology & Sexual Health · doi:10.1002/tre.118 · Cited by 3
Watchful waiting versus prostatectomy for prostate cancer
Hegarty, J. M., Beirne, P. V., Comber, H., & Wallace, M. E. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006590 · Cited by 3
Oncologic Outcomes of Laparoscopic Radical Prostatectomy: Intermediate-Term Follow-up
Secin, F. P., Bianco, F. J., Karanikolas, N. T., Touijer, K. A., & Guillonneau, B. D. (2006) · European Urology Supplements · doi:10.1016/j.eursup.2006.08.001 · Cited by 3
Do We Need the Final Results of the ERSPC Trial?
Albers, P. (2006) · European Urology · doi:10.1016/j.eururo.2006.07.044 · Cited by 3
Prostate cancer: screening approaches
Donovan, J., Martin, R., & Neal, D. E. (2005) · British Journal of Hospital Medicine · doi:10.12968/hmed.2005.66.11.20023 · Cited by 4
Response to “CT Screening for Lung Cancer: Update 2007”
Bach, P. B. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0031 · Cited by 3
Sandler, H. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.7612 · Cited by 3
Fitzgerald, S. P. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.04.008 · Cited by 3
Population screening for prostate cancer
Bryant, R. J., Roobol, M. J., & Hamdy, F. C. (2018) · doi:10.1002/9781118990957.ch13 · Cited by 3
Gonzales, J., Adilbay, D., França, P. D. D. S., Artschwager, R., Chow, C. Y., Viray, T. D., Johnson, D. S., Jiang, Y., Patel, S. G., Ganly, I., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.06.588368 · Cited by 3
Andersen, H. R., Nolsøe, A. B., Durukan, E., Østergren, P. B., Jensen, C. F. S., Sønksen, J., & Fode, M. M. (2026) · International Journal of Impotence Research · doi:10.1038/s41443-025-01185-5 · Cited by 2
Watchful waiting in incidental adenocarcinoma of the prostate
Pascual, E. J. M., Sacoto, C. D. C., Villa, M. T., Moreno, J. L. P., Cerdá, J. L. R., & Cruz, J. F. J. (2010) · Actas Urológicas Españolas (English Edition) · doi:10.1016/s2173-5786(10)70213-4 · Cited by 2
Metadata
- Authors
- Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., Palmgren, J., Adami, H.-O., Norlén, B. J., & Johansson, J.-E.
- Affiliations
- University of Helsinki (FI)
- Linköping University Hospital (SE)
- Uppsala University Hospital (SE)
- Karolinska Institutet (SE)
- Harvard University (US)
- Örebro University Hospital (SE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-05-12
- Volume
- 352
- Issue
- 19
- Pages
- 1977-1984
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4233182856
- Cited by
- 1,111
- References
- 11
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 18 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 23 · 2018: 21 · 2017: 20 · 2016: 24 · 2015: 35 · 2014: 35 · 2013: 50 · 2012: 68
- FWCI
- 120.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- radical prostatectomy, expectant management, early-stage prostate cancer, prostate cancer mortality, distant metastasis, local tumor progression, all-cause mortality, long-term follow-up, surgical versus conservative treatment
- MeSH terms
- Aged, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Metastasis, Prostatectomy, Prostatic Neoplasms, Incidence, Proportional Hazards Models, Survival Analysis, Disease Progression, Antineoplastic Agents, Hormonal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.